News

Amgen’s Stelara biosimilar gets off to fast start
Sales of the company’s copycat to J&J’s blockbuster medicine reached $150 million in the first quarter, adding to a surge in ...
Zacks Investment Research on MSN21h
Amgen's Q1 Earnings Beat Estimates, Key Drugs Drive Sales Growth
Amgen AMGN reported first-quarter 2025 adjusted earnings of $4.90 per share, which beat the Zacks Consensus Estimate of $4.16 ...